Makarova Alexandra, Mikhailenko Irina, Bugge Thomas H, List Karin, Lawrence Daniel A, Strickland Dudley K
Department of Vascular Biology, Holland Laboratory, American Red Cross, Rockville, Maryland 20855, USA.
J Biol Chem. 2003 Dec 12;278(50):50250-8. doi: 10.1074/jbc.M309150200. Epub 2003 Sep 30.
Proteases contribute to a variety of processes in the brain; consequently, their activity is carefully regulated by protease inhibitors, such as neuroserpin. This inhibitor is thought to be secreted by axons at synaptic regions where it controls tissue-type plasminogen activator (tPA) activity. Mechanisms regulating neuroserpin are not known, and the current studies were undertaken to define the cellular pathways involved in neuroserpin catabolism. We found that both active neuroserpin and neuroserpin.tPA complexes were internalized by mouse cortical cultures and embryonic fibroblasts in a process mediated by the low density lipoprotein receptor-related protein (LRP). Surprisingly, despite the fact that active neuroserpin is internalized by LRP, this form of the molecule does not directly bind to LRP on its own, indicating the requirement of a cofactor for neuroserpin internalization. Our studies ruled out the possibility that endogenously produced plasminogen activators (i.e. tPA and urokinase-type plasminogen activator) are responsible for the LRP-mediated internalization of active neuroserpin, but could not rule out the possibility that another cell-associated proteases capable of binding active neuroserpin functions in this capacity. In summary, neuroserpin levels appear to be carefully regulated by LRP and an unidentified cofactor, and this pathway may be critical for maintaining the balance between proteases and inhibitors.
蛋白酶在大脑的多种过程中发挥作用;因此,它们的活性受到蛋白酶抑制剂(如神经丝氨酸蛋白酶抑制剂)的严格调控。这种抑制剂被认为是由轴突在突触区域分泌的,在该区域它控制组织型纤溶酶原激活剂(tPA)的活性。调节神经丝氨酸蛋白酶抑制剂的机制尚不清楚,目前的研究旨在确定参与神经丝氨酸蛋白酶抑制剂分解代谢的细胞途径。我们发现,活性神经丝氨酸蛋白酶抑制剂和神经丝氨酸蛋白酶抑制剂.tPA复合物在低密度脂蛋白受体相关蛋白(LRP)介导的过程中被小鼠皮质培养物和胚胎成纤维细胞内化。令人惊讶的是,尽管活性神经丝氨酸蛋白酶抑制剂被LRP内化,但这种分子形式本身并不直接与LRP结合,这表明神经丝氨酸蛋白酶抑制剂内化需要一种辅助因子。我们的研究排除了内源性产生的纤溶酶原激活剂(即tPA和尿激酶型纤溶酶原激活剂)负责LRP介导的活性神经丝氨酸蛋白酶抑制剂内化的可能性,但不能排除另一种能够结合活性神经丝氨酸蛋白酶抑制剂的细胞相关蛋白酶具有这种功能的可能性。总之,神经丝氨酸蛋白酶抑制剂的水平似乎受到LRP和一种未确定的辅助因子的严格调控,并且这条途径可能对维持蛋白酶和抑制剂之间的平衡至关重要。